This observational study investigates modifiable lifestyle and environmental factors that may influence the risk, progression, and severity of Parkinson's disease and related disorders, including Progressive Supranuclear Palsy, Multiple System Atrophy, and Corticobasal Degeneration.
While genetic factors contribute to Parkinson's disease risk, the majority of cases are sporadic, suggesting that environmental and lifestyle factors play a significant role. This study aims to characterize these modifiable factors to identify potential prevention strategies and disease-modifying interventions.
Parkinson's disease affects approximately 1-2% of the population over 65 years, rising to 3-5% in those over 85. The global prevalence is estimated at over 10 million people. Key epidemiological features include:
- Slight male predominance (1.5:1 ratio)
- Typical onset between 50-70 years
- Increasing incidence with age
- Geographic variation in prevalence
| Parameter |
Value |
| NCT Number |
NCT02194816 |
| Status |
Recruiting |
| Study Type |
Observational |
| Conditions |
Parkinson's Disease, PSP, MSA, CBS |
| Sites |
United States (multiple centers) |
| Enrollment |
Target: Multiple participants |
| Start Date |
2014 |
Multiple factors influence Parkinson's disease risk:
- Age (strongest risk factor)
- Male sex
- Genetic susceptibility (family history, specific genes)
- Ethnic background
- Pesticide exposure
- Head trauma
- Dairy product consumption
- Psychological stress
- Caffeine consumption
- Physical activity
- Smoking (controversial - nicotine vs. confounding)
- Alcohol consumption (moderate)
- Anti-inflammatory drug use
-
Characterize Lifestyle Factors
- Document caffeine and nicotine use
- Assess physical activity levels
- Evaluate dietary patterns
- Record medication history
-
Assess Environmental Exposures
- Occupational history
- Pesticide exposure assessment
- Living environment
- Water source
-
Correlate with Clinical Outcomes
- Disease severity measures
- Progression rates
- Motor and non-motor symptoms
- Treatment response
-
Identify Intervention Targets
- Risk factor quantification
- Protective factor validation
- Target population identification
- Evaluate gender-specific effects
- Assess age-of-onset relationships
- Characterize gene-environment interactions
- Develop risk prediction models
¶ Caffeine and Nicotine Use
Epidemiological studies consistently show inverse associations between caffeine consumption and Parkinson's disease risk:
- Coffee consumption: 30-60% risk reduction in meta-analyses
- Tea consumption: similar inverse association
- Caffeine dose-response relationship
- Potential neuroprotective mechanisms:
- Adenosine A2A receptor antagonism
- Antioxidant effects
- Anti-inflammatory properties
Nicotine has also been studied extensively:
- Historical smoking association with reduced PD risk
- Contributes to inverse association in some studies
- Confounded by lifestyle factors
- Nicotinic receptor modulation as therapeutic target
Exercise and physical activity have emerged as potentially disease-modifying interventions:
- Regular exercise associated with 30-50% risk reduction
- Mechanisms include:
- Neurotrophic factor upregulation
- Mitochondrial function improvement
- Neuroinflammation reduction
- Alpha-synuclein clearance enhancement
- Recommended exercise types:
- Aerobic exercise
- Balance training
- Resistance training
- Dance-based therapies
Nutritional factors influence Parkinson's disease risk:
Certain medications may modify Parkinson's disease risk:
- Statins: Conflicting evidence - some studies show reduced risk
- NSAIDs: Mixed results for anti-inflammatory effects
- Beta-blockers: Theoretical benefits via adrenergic modulation
- Calcium channel blockers: Some protective signals
Pesticide and chemical exposures represent significant risk factors:
- Herbicides: Paraquat, rotenone
- Insecticides: Organophosphates, pyrethroids
- Fungicides: Maneb, mancozeb
Mechanisms of neurotoxicity:
- Mitochondrial complex I inhibition
- Oxidative stress induction
- Alpha-synuclein aggregation promotion
- Dopaminergic neuron selectivity
- Agricultural workers
- Pesticide applicators
- Farm managers
- Greenhouse workers
Protective Measures:
- Personal protective equipment
- Engineering controls
- Safe handling practices
- Rotation of duties
The gold-standard assessment tool:
- Part I: Non-motor experiences of daily living
- Part II: Motor experiences of daily living
- Part III: Motor examination
- Part IV: Motor complications
¶ Hoehn and Yahr Staging
- Stage 0: No signs of disease
- Stage 1: Unilateral involvement
- Stage 1.5: Unilateral and axial involvement
- Stage 2: Bilateral involvement without impairment
- Stage 2.5: Mild bilateral disease with recovery on pull test
- Stage 3: Mild to moderate disease, some postural instability
- Stage 4: Severe disability, still able to walk/stand
- Stage 5: Wheelchair-bound or bedridden
For PSP and related disorders:
- Gait and mobility
- Ocular motor dysfunction
- Dysphagia
- Cortical dysfunction
- Axonal rigidity
- Montreal Cognitive Assessment (MoCA)
- Trail Making Test
- Word fluency
- Memory recall
- Beck Depression Inventory
- State-Trait Anxiety Inventory
- apathy assessment
- REM sleep behavior disorder questionnaire
- Epworth Sleepiness Scale
- Polysomnography when indicated
- Parkinson's Disease Questionnaire-39 (PDQ-39)
- SF-36 Health Survey
- Caregiver burden scales
-
Diagnosis of Parkinsonian Syndrome
- Clinical diagnosis of Parkinson's disease, PSP, MSA, or CBS
- UK Brain Bank criteria or equivalent
- Progressive disease course
-
Age Requirements
- Age 40-90 years
- Disease duration any stage
-
Ability to Participate
- Able to complete questionnaires
- Available for study visits
- Informed consent obtained
-
Secondary Parkinsonism
- Drug-induced parkinsonism
- Vascular parkinsonism
- Normal pressure hydrocephalus
-
Medical Contraindications
- Unable to complete study procedures
- Terminal illness
- Severe cognitive impairment preventing consent
- Baseline lifestyle questionnaire
- Environmental exposure assessment
- Clinical phenotype characterization
- Annual follow-up assessments
- Disease progression tracking
- Change in exposure status documentation
- Interviewer-administered questionnaires
- Self-administered diaries
- Medical record review
- Biological sample collection
¶ Understanding Disease Mechanisms
This study contributes to understanding how environmental factors influence neurodegenerative processes:
-
Gene-Environment Interactions
- How genetic susceptibility modifies environmental risk
- Epigenetic modifications from exposures
-
Mechanistic Insights
- Identification of environmental triggers
- Understanding of protective mechanisms
Identifying modifiable risk factors enables development of prevention strategies:
-
Primary Prevention
- Reducing pesticide exposure
- Promoting physical activity
- Dietary modifications
-
Secondary Prevention (Early Intervention)
- Early identification of prodromal markers
- Intervention before significant neurodegeneration
-
Disease Modification
- Targeting mechanisms influenced by lifestyle
- Complementing pharmacological approaches
- Risk Factor Modification: Lifestyle interventions as adjuncts to pharmacological treatments
- Endpoint Selection: Environmental factors affecting progression
- Patient Stratification: Exposure-based phenotyping
- Neuroprotective Trials: Environmental modifiers as targets
¶ Limitations and Challenges
- Cannot establish causality
- Potential for confounding
- Recall bias in exposure assessment
- Latency between exposure and disease
- Difficulty quantifying exposures
- Recall limitations
- Geographic specificity
- Referral bias
- Cohort representativeness